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Adipose tissue’s secretory phenotype paradigm shift has been upregulating since December 1, 1994, the birthday of leptin, an 
endocrine signaling  protein (adipokine), which triggered the development of adipoendocrinology. Today, more than hundred 
adipokines are identified. Here an update of adipose-derived neurotrophic factors and neuropeptides and their receptors is 
presented, raising a hypothesis of neuroendocrine potential of this dynamic tissue. Biomed Rev 2008; 19: 45-48.
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INTRODUCTION
Today, adipose tissue (mainly its white phenotype) is increas-
ingly recognized as a dynamic tissue which may, by sending 
and receiving different types of protein and non-protein sig-
nals,  communicate with many organs in the human’s body. 
Indeed, an extensive body of work has revealed that adipose 
tissue expresses not only metabolic, but also endo-, auto-, 
intra- and paracrine phenotypes. This new biology is achieved 
predominantly through synthesis, storage, and release (that is, 
secretion) of adipokines, which include more than hundred 
highly active signaling proteins abundantly secreted by adipose 
tissue, particularly when hypertrophied, inflamed or other re-
lated conditions (1-12). These factors may contribute to brain, 
immune, vascular and metabolic functions, including feeding 
behavior, memory, learning, circadial  rhytm, inflammation, 
immunity, vascular tone, and insulin resistance. 
There is at present evidence that the sharing of ligands 
(growth factors, cytokines, and adipokines) and their receptors 
constitute a “global” molecular language of the human’s body, 
including neural, immune and adipose cells. For instance, 
leptin and adiponectin exert effects on hypothalamus, sympa-
thetic nerves and immune cells (reviewed in 5-7, 13, also see 
14-16). Noteworthy, though the brain has been recognized as 
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a prominent site of neuropeptide synthesis for more than 30 
years, it was recently be discovered that adipose-specific genes 
(e.g. for leptin, resistin and adiponectin) are also expressed 
in the brain (17,18), and that leptin exerts neuroprotective 
effect (19,20). Moreover, substance P, neuropeptide tyrosine 
(NPY), calcitonin gene-related protein, kisspeptin and other 
neuropeptides (21-26) as well as amino acid neurotransmitters 
(27) are also produced by adipose tissue. In the same vein, 
most hypothalamic and pituitary neuropeptides, hormones and 
releasing factors, termed “adipotrophins” (28), express their 
receptors in adipose tissue, creating hypothalamic-pituitary-
adipose axis (29), and possibly, pineal-adipose axis. Further, 
adipose stem cells appear to be a promising therapeutic tool in 
brain injury (30,31). Noteworthy, various neurotrophic factors 
including nerve growth factor (NGF), brain-derived neuro-
trophic factor (24,32-36), also vascular endothelial growth 
factor and angiopoietin (37-39), are produced and released 
from adipose tissue. 
While NGF was first discovered by Rita Levi-Montalcini 
in 1951 as nerve growth stimulating factor produced in largest 
amount by submandibular glands (40, also 41 for extraneu-
ronal actions of NGF, and 42,43 for BDNF), it appears today 
that the adipose tissue might be a major biological source of 
NGF and other neurotrophic factors as well as neuropeptides 
and neurotransmitters, selected examples being indicated in 
Table 1. Altogether, this complex secretory capacity raises 
a hypothesis of neuroendocrine potential of adipose tissue.
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Table 1. Adipose tissue-produced factors affecting nerve cells*
Neuropeptides
Neuropeptide tyrosine (NPY) 
Substance P 






Nerve growth factor 
Brain-derived neurotrophic factor 
Ciliary neurotrophic factor 
Metallothioneins
Glial cell line-derived neurotrophic factor 
Angiopoietin-1 
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